Federal
Comprehensive TB Elimination Act of 2019
Source: Congress.gov ·
1,527 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
II
116TH CONGRESS
1ST SESSION
S. 834
To amend the Public Health Service Act to enhance the national strategy
for combating and eliminating tuberculosis, and for other purposes.
IN THE SENATE OF THE UNITED STATES
MARCH 14, 2019
Mr. BROWN introduced the following bill; which was read twice and referred
to the Committee on Health, Education, Labor, and Pensions
A BILL
To amend the Public Health Service Act to enhance the
national strategy for combating and eliminating tuber-
culosis, and for other purposes.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Comprehensive TB
4
Elimination Act of 2019’’.
5
SEC. 2. NATIONAL STRATEGY FOR COMBATING AND ELIMI-
6
NATING TUBERCULOSIS.
7
(a) IN GENERAL.—Section 317E of the Public
8
Health Service Act (42 U.S.C. 247b–6) is amended—
9
(1) in subsection (a)—
10
VerDate Sep 11 2014
00:22 Mar 29, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\S834.IS
S834
pamtmann on DSKBFK8HB2PROD with BILLS
2
•S 834 IS
(A) by striking ‘‘The Secretary’’ and in-
1
serting the following:
2
‘‘(1) GRANTS.—The Secretary’’; and
3
(B) by adding at the end the following:
4
‘‘(2) PRIORITY.—In making grants under this
5
subsection, the Secretary may give priority to award-
6
ing grants to State health departments proposing to
7
focus on the prevention, control, and elimination of
8
tuberculosis in high-risk populations, including for-
9
eign-born, homeless, incarcerated, HIV-tuberculosis
10
coinfected, and medically underserved populations.’’;
11
(2) in subsection (b)—
12
(A) in paragraph (3)—
13
(i) in subparagraph (C), by redesig-
14
nating clauses (i) and (ii) as subclauses (I)
15
and (II), respectively, and adjusting the
16
margins accordingly; and
17
(ii) by redesignating subparagraphs
18
(A) through (F) as clauses (i) through (vi),
19
respectively, and adjusting the margins ac-
20
cordingly;
21
(B)
by
redesignating
paragraphs
(1)
22
through (8) as subparagraphs (A) through (H),
23
respectively, and adjusting the margins accord-
24
ingly;
25
VerDate Sep 11 2014
00:22 Mar 29, 2019
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\S834.IS
S834
pamtmann on DSKBFK8HB2PROD with BILLS
3
•S 834 IS
(C) in the matter preceding subparagraph
1
(A), as so redesignated, by striking ‘‘With re-
2
spect to’’ and inserting the following:
3
‘‘(1) IN GENERAL.—With respect to’’;
4
(D) by striking subparagraph (B), as so
5
redesignated, and inserting the following:
6
‘‘(B) Research, investigations, experiments,
7
demonstrations, and studies in the health
8
sciences that are related to—
9
‘‘(i) the development of new tools, in-
10
cluding vaccines and antimicrobial drugs,
11
to prevent and treat tuberculosis;
12
‘‘(ii) novel therapeutics for special
13
populations,
including
pediatric
popu-
14
lations, immunosuppressed individuals, and
15
pregnant women;
16
‘‘(iii) the development or testing of
17
medical diagnostics to detect tuberculosis;
18
‘‘(iv) research to address the epidemi-
19
ology, mechanisms, and pathogenesis of tu-
20
berculosis;
21
‘‘(v) public health interventions to ad-
22
dress the prevention, treatment, and con-
23
trol of tuberculosis, such as directly ob-
24
VerDate Sep 11 2014
00:22 Mar 29, 2019
Jkt 089200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\S834.IS
S834
pamtmann on DSKBFK8HB2PROD with BILLS
4
•S 834 IS
served therapy and non-pharmaceutical
1
intervention;
2
‘‘(vi) methods to enhance detection
3
and response to outbreaks of tuberculosis,
4
including multidrug resistant tuberculosis;
5
and
6
‘‘(vii) other relevant research areas.’’;
7
(E) in subparagraph (C), as so redesig-
8
nated—
9
(i) by redesignating clause (vi), as so
10
redesignated, as clause (vii);
11
(ii) in clause (v), as so redesignated,
12
by striking ‘‘; and’’ and inserting ‘‘;’’; and
13
(iii) by inserting after clause (v), as so
14
redesignated, the following:
15
‘‘(vi) the intensification of efforts to
16
prevent, detect, and treat latent tuber-
17
culosis; and’’;
18
(F) in subparagraph (D), as so redesig-
19
nated, by inserting before the period the fol-
20
lowing: ‘‘, including public awareness campaigns
21
and development of educational, risk, and
22
media communications.’’;
23
(G) in subparagraph (F), as so redesig-
24
nated, by striking ‘‘paragraphs (1) through
25
VerDate Sep 11 2014
00:22 Mar 29, 2019
Jkt 089200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\S834.IS
S834
pamtmann on DSKBFK8HB2PROD with BILLS
5
•S 834 IS
(4)’’ and inserting ‘‘subparagraphs (A) through
1
(D)’’; and
2
(H) by adding at the end the following:
3
‘‘(2) SELECTION.—In carrying out the activities
4
described in paragraph (1), the Secretary—
5
‘‘(A) is encouraged to give priority to pro-
6
grammatically relevant research so that new
7
tools can be utilized in public health practice;
8
and
9
‘‘(B) may seek input from the Biomedical
10
Advanced Research and Development Authority
11
in identifying novel candidates to utilize in the
12
efforts under this subsection to prevent, diag-
13
nose, and control tuberculosis.’’;
14
(3) by redesignating subsections (c) through (h)
15
as subsections (d) through (i), respectively;
16
(4) by inserting after subsection (b) the fol-
17
lowing—
18
‘‘(c) GRANTS FOR COORDINATION OF PROGRAMS AND
19
SERVICES FOR PREVENTION, DIAGNOSIS, AND TREAT-
20
MENT.—
21
‘‘(1) GRANTS.—The Secretary, acting through
22
the Administrator of the Health Resources and Serv-
23
ices Administration, may award grants to State and
24
local governments and Federally qualified health
25
VerDate Sep 11 2014
00:22 Mar 29, 2019
Jkt 089200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\S834.IS
S834
pamtmann on DSKBFK8HB2PROD with BILLS
6
•S 834 IS
centers for coordinating the programs and services
1
of such States, governments, and centers to ensure
2
timely and appropriate prevention, risk-based screen-
3
ing, diagnosis, and treatment of latent and active tu-
4
berculosis.
5
‘‘(2) DEFINITION.—In this subsection, the term
6
‘Federally qualified health center’ has the meaning
7
given to such term in section 1861(aa) of the Social
8
Security Act.’’;
9
(5) in subsections (d), (e), and (f), as so redes-
10
ignated, by striking ‘‘(a) or (b)’’ each place it ap-
11
pears and inserting ‘‘(a), (b), or (c)’’;
12
(6) in subsection (g)(4), as so redesignated, by
13
adding at the end the following:
14
‘‘(C) REPORT
TO
CONGRESS.—The Sec-
15
retary is encouraged to make the reports under
16
subparagraph (A), or other publications rel-
17
evant to domestic tuberculosis surveillance, pub-
18
licly available on the internet website of the
19
Centers for Disease Control and Prevention and
20
to disseminate such information to stake-
21
holders.’’;
22
(7) in subsection (h), as so redesignated—
23
(A) in paragraph (1)—
24
VerDate Sep 11 2014
00:22 Mar 29, 2019
Jkt 089200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\S834.IS
S834
pamtmann on DSKBFK8HB2PROD with BILLS
7
•S 834 IS
(i) by striking ‘‘research into new
1
tools under subsection (b)(2)’’ and insert-
2
ing ‘‘the research, investigations, experi-
3
ments, demonstrations, and studies in
4
health science under subsection (b)(1)(B)’’;
5
and
6
(ii) by inserting ‘‘ensuring access to
7
the products developed as a result of such
8
research, investigations, experiments, dem-
9
onstrations, and studies and’’ after ‘‘advice
10
regarding’’; and
11
(B) in paragraph (3)—
12
(i) by redesignating subparagraphs
13
(D) and (E) as subparagraphs (E) and
14
(F), respectively; and
15
(ii) by inserting after subparagraph
16
(C) the following:
17
‘‘(D) members of the Biomedical Advanced
18
Research and Development Authority;’’; and
19
(8) in subsection (i)(1)(A), as so redesignated,
20
by striking ‘‘$200,000,000’’ and all that follows
21
through the period and inserting ‘‘$142,200,000 for
22
fiscal year 2020, $195,700,000 for fiscal year 2021,
23
$225,000,000 for fiscal year 2022, $236,250,000 for
24
VerDate Sep 11 2014
00:22 Mar 29, 2019
Jkt 089200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\S834.IS
S834
pamtmann on DSKBFK8HB2PROD with BILLS
8
•S 834 IS
fiscal year 2023, $248,062,500 for fiscal year 2024,
1
and $260,465,625 for fiscal year 2025.’’.
2
(b)
NIH
TUBERCULOSIS
ACTIVITIES.—Section
3
424C(b) of the Public Health Service Act (42 U.S.C.
4
285b–7c(b)) is amended by striking paragraph (1) and in-
5
serting the following:
6
‘‘(1) enhancing basic, clinical, and operational
7
research on tuberculosis, including with respect to—
8
‘‘(A) drug-resistant tuberculosis;
9
‘‘(B) infection with tuberculosis and la-
10
tency and progression of tuberculosis; and
11
‘‘(C) pediatric tuberculosis;’’.
12
SEC. 3. GAO STUDY.
13
Not later than 2 years after the date of enactment
14
of this Act, the Comptroller General of the United States
15
shall issue a report on the coordination of efforts in the
16
United States to—
17
(1) prevent, control, and eliminate tuberculosis;
18
and
19
(2) implement the activities under section 317E
20
of the Public Health Service Act (42 U.S.C. 247b–
21
6), as amended by this Act, and the National Action
22
Plan for Combating Multidrug-Resistant Tuber-
23
culosis, issued in December 2015.
24
Æ
VerDate Sep 11 2014
00:22 Mar 29, 2019
Jkt 089200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6301
E:\BILLS\S834.IS
S834
pamtmann on DSKBFK8HB2PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.